# OFG Bancorp: financial statements, quarterly

OFG · NYSE · CIK 1030469 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ofg.md) · [Financials](/companies/ofg/financials.md) · [Filings](/companies/ofg/filings.md) · [Insiders](/companies/ofg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ofg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001030469-24-000042.md) | [0.0 d](/filings/0001030469-24-000007.md) | [0.0](/filings/0001030469-24-000019.md) | [0.0](/filings/0001030469-24-000031.md) | [0.0](/filings/0001030469-24-000042.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [23.9](/filings/0001030469-23-000040.md) | [32.7 d](/filings/0001030469-24-000007.md) | [39.3](/filings/0001030469-24-000019.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [21.0](/filings/0001030469-24-000042.md) | [21.8 d](/filings/0001030469-26-000008.md) | [18.2](/filings/0001030469-25-000019.md) | [20.1](/filings/0001030469-25-000044.md) | [14.8](/filings/0001030469-25-000051.md) | [2.4 d](/filings/0001030469-26-000008.md) | [13.9](/filings/0001030469-26-000027.md) | [14.1](/filings/0001030469-26-000038.md) | [9.5](/filings/0001030469-25-000051.md) | [(8.5) d](/filings/0001030469-26-000008.md) | [14.9](/filings/0001030469-26-000027.md) | [15.7](/filings/0001030469-26-000038.md) |
| Net income | $m | [44.9](/filings/0001030469-24-000042.md) | [46.6 d](/filings/0001030469-26-000008.md) | [49.7](/filings/0001030469-25-000019.md) | [51.1](/filings/0001030469-25-000044.md) | [47.0](/filings/0001030469-25-000051.md) | [50.3 d](/filings/0001030469-26-000008.md) | [45.6](/filings/0001030469-26-000027.md) | [51.8](/filings/0001030469-26-000038.md) | [51.8](/filings/0001030469-25-000051.md) | [55.9 d](/filings/0001030469-26-000008.md) | [53.9](/filings/0001030469-26-000027.md) | [58.8](/filings/0001030469-26-000038.md) |
| Diluted EPS | $ per share | [0.95](/filings/0001030469-24-000042.md) | not reported | [1.05](/filings/0001030469-25-000019.md) | [1.08](/filings/0001030469-25-000044.md) | [1.00](/filings/0001030469-25-000051.md) | not reported | [1.00](/filings/0001030469-26-000027.md) | [1.15](/filings/0001030469-26-000038.md) | [1.16](/filings/0001030469-25-000051.md) | not reported | [1.26](/filings/0001030469-26-000027.md) | [1.39](/filings/0001030469-26-000038.md) |
| Basic EPS | $ per share | [0.95](/filings/0001030469-24-000042.md) | not reported | [1.06](/filings/0001030469-25-000019.md) | [1.09](/filings/0001030469-25-000044.md) | [1.01](/filings/0001030469-25-000051.md) | not reported | [1.01](/filings/0001030469-26-000027.md) | [1.15](/filings/0001030469-26-000038.md) | [1.17](/filings/0001030469-25-000051.md) | not reported | [1.26](/filings/0001030469-26-000027.md) | [1.39](/filings/0001030469-26-000038.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001030469-23-000040.md) | [0.7](/filings/0001030469-25-000007.md) | [0.8](/filings/0001030469-24-000019.md) | [0.7](/filings/0001030469-24-000031.md) | [0.7](/filings/0001030469-24-000042.md) | [0.6](/filings/0001030469-26-000008.md) | [0.7](/filings/0001030469-25-000019.md) | [0.9](/filings/0001030469-25-000044.md) | [0.7](/filings/0001030469-25-000051.md) | [1.0](/filings/0001030469-26-000038.md) | [0.6](/filings/0001030469-26-000027.md) | [0.7](/filings/0001030469-26-000038.md) |
| Total assets | $bn | [10.3](/filings/0001030469-24-000042.md) | [11.3](/filings/0001030469-26-000008.md) | [11.2](/filings/0001030469-25-000019.md) | [11.3](/filings/0001030469-25-000044.md) | [11.5](/filings/0001030469-25-000051.md) | [11.5](/filings/0001030469-26-000008.md) | [11.7](/filings/0001030469-26-000027.md) | [12.2](/filings/0001030469-26-000038.md) | [12.2](/filings/0001030469-25-000051.md) | [12.5](/filings/0001030469-26-000038.md) | [12.0](/filings/0001030469-26-000027.md) | [12.2](/filings/0001030469-26-000038.md) |
| Total liabilities | $bn | [9.2](/filings/0001030469-23-000040.md) | [10.2](/filings/0001030469-25-000007.md) | [9.9](/filings/0001030469-24-000019.md) | [10.0](/filings/0001030469-24-000031.md) | [10.1](/filings/0001030469-24-000042.md) | [10.2](/filings/0001030469-26-000008.md) | [10.4](/filings/0001030469-25-000019.md) | [10.9](/filings/0001030469-25-000044.md) | [10.9](/filings/0001030469-25-000051.md) | [11.1](/filings/0001030469-26-000038.md) | [10.7](/filings/0001030469-26-000027.md) | [10.7](/filings/0001030469-26-000038.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.1](/filings/0001030469-24-000042.md) | [1.2](/filings/0001030469-26-000008.md) | [1.2](/filings/0001030469-25-000019.md) | [1.2](/filings/0001030469-25-000044.md) | [1.3](/filings/0001030469-25-000051.md) | [1.3](/filings/0001030469-26-000008.md) | [1.3](/filings/0001030469-26-000027.md) | [1.3](/filings/0001030469-26-000038.md) | [1.4](/filings/0001030469-25-000051.md) | [1.4](/filings/0001030469-26-000038.md) | [1.4](/filings/0001030469-26-000027.md) | [1.4](/filings/0001030469-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [88.8 d](/filings/0001030469-24-000042.md) | [108 d](/filings/0001030469-26-000008.md) | [61.0](/filings/0001030469-25-000019.md) | [95.1 d](/filings/0001030469-25-000044.md) | [58.1 d](/filings/0001030469-25-000051.md) | [38.3 d](/filings/0001030469-26-000008.md) | [83.1](/filings/0001030469-26-000027.md) | [35.9 d](/filings/0001030469-26-000038.md) | [39.5 d](/filings/0001030469-25-000051.md) | [59.2 d](/filings/0001030469-26-000008.md) | [73.1](/filings/0001030469-26-000027.md) | [53.2 d](/filings/0001030469-26-000038.md) |
| Capital expenditure | $m | [4.0 d](/filings/0001030469-24-000042.md) | [6.2 d](/filings/0001030469-26-000008.md) | [6.2](/filings/0001030469-25-000019.md) | [4.7 d](/filings/0001030469-25-000044.md) | [6.4 d](/filings/0001030469-25-000051.md) | [4.1 d](/filings/0001030469-26-000008.md) | [4.4](/filings/0001030469-26-000027.md) | [4.1 d](/filings/0001030469-26-000038.md) | [4.0 d](/filings/0001030469-25-000051.md) | [5.9 d](/filings/0001030469-26-000008.md) | [4.4](/filings/0001030469-26-000027.md) | [8.1 d](/filings/0001030469-26-000038.md) |
| Dividends paid | $m | [10.4 d](/filings/0001030469-24-000042.md) | [10.5 d](/filings/0001030469-26-000008.md) | [10.4](/filings/0001030469-25-000019.md) | [11.9 d](/filings/0001030469-25-000044.md) | [11.7 d](/filings/0001030469-25-000051.md) | [11.6 d](/filings/0001030469-26-000008.md) | [11.5](/filings/0001030469-26-000027.md) | [13.6 d](/filings/0001030469-26-000038.md) | [13.5 d](/filings/0001030469-25-000051.md) | [13.4 d](/filings/0001030469-26-000008.md) | [13.1](/filings/0001030469-26-000027.md) | [14.9 d](/filings/0001030469-26-000038.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [47.9](/filings/0001030469-23-000040.md) | [47.9](/filings/0001030469-24-000019.md) | [47.5](/filings/0001030469-24-000031.md) | [47.4](/filings/0001030469-24-000042.md) | [47.3](/filings/0001030469-25-000019.md) | [47.1](/filings/0001030469-25-000044.md) | [46.8](/filings/0001030469-25-000051.md) | [45.5](/filings/0001030469-26-000027.md) | [45.0](/filings/0001030469-26-000038.md) | [44.7](/filings/0001030469-25-000051.md) | [43.0](/filings/0001030469-26-000027.md) | [42.4](/filings/0001030469-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,265,494 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001030469-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.